Skip to main content
Syncona Limited logo

Syncona Limited — Investor Relations & Filings

Ticker · SYNC ISIN · GG00B8P59C08 LEI · 213800X8MBI5VQITLW60 IL Financial and insurance activities
Open in API
Filings indexed 1,030 across all filing types
Latest filing 2024-07-03 AGM Information
Country GG Guernsey
Listing IL SYNC

About Syncona Limited

https://www.synconaltd.com/

Syncona Limited is a life science investment company focused on founding, building, and funding a portfolio of healthcare businesses. The company's strategy is to identify and advance exceptional science to create globally leading companies capable of delivering transformational treatments to patients, particularly in areas with high unmet medical needs. Its portfolio is concentrated in innovative therapeutic areas, including gene therapy, cell therapy, and biologics. Syncona actively manages its companies to reach key value inflection points, aiming to generate significant long-term capital appreciation for shareholders through strategic events such as mergers, acquisitions, and other liquidity events.

Recent filings

Filing Released Lang Actions
Notice of the 2024 Annual General Meeting
AGM Information Classification · 1% confidence The document explicitly states in the main heading: "Notice of the 2024 Annual General Meeting". It details the date, time, and location of the AGM, provides a letter from the Chair recommending votes on various resolutions (including reappointing auditors, re-electing directors, and seeking authorities for share allotment/repurchase), and outlines the required voting majorities. This content perfectly matches the definition of materials distributed in connection with an Annual General Meeting (AGM). Therefore, the classification is AGM-R.
2024-07-03 English
Notice of AGM
Report Publication Announcement Classification · 1% confidence The document explicitly states it is an announcement regarding the 'Publication of 2024 Annual Report and Notice of Annual General Meeting'. It mentions that these documents are being filed with the National Storage Mechanism and provides links to where they can be found, rather than containing the full content of the Annual Report (10-K) or the AGM materials themselves. The document length is short (3785 chars), fitting the 'MENU VS MEAL' rule. Since it announces the publication of both the Annual Report and the AGM Notice, the most appropriate classification is Report Publication Announcement (RPA), as it is primarily an announcement about the release of other documents.
2024-07-03 English
Beacon raises $170 million in a Series B financing
Share Issue/Capital Change Classification · 1% confidence The document is an official announcement disseminated via the RNS (Regulatory News Service) system, indicated by the 'RNS Number' header and the concluding paragraph mentioning RNS and the London Stock Exchange. The content details a significant financing event ($170 million Series B) for a portfolio company (Beacon Therapeutics) and Syncona's investment commitment and resulting valuation uplift. This type of announcement, which is a material corporate event disclosure but not a full financial report (like 10-K or IR) or a specific management/director transaction, fits best under the general regulatory announcement category. Since it is a formal regulatory news service release, the most appropriate code is RNS, as it serves as the primary channel for such disclosures.
2024-07-03 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states its purpose in the title section: "Transaction in Own Shares". It details the number of ordinary shares purchased by the company on a specific date (02 July 2024) as part of a previously announced share buyback programme. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS), which covers company repurchases. The presence of the RNS Number and the closing statement confirming the information is provided by RNS (the news service of the London Stock Exchange) confirms it is a regulatory disclosure, but the specific content dictates the most precise code.
2024-07-03 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states the subject is 'Transaction in Own Shares' and details the purchase of 110,000 ordinary shares by the company as part of its 'share buyback programme'. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The presence of the RNS Number and the closing statement referencing RNS confirms it is a regulatory announcement, but the specific content dictates the most precise classification is POS.
2024-07-02 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a short announcement (2822 characters) issued via RNS (Regulatory News Service) on July 1, 2024. It explicitly states the 'Total Voting Rights' as of June 30, 2024, referencing DTR 5.6.1 (Disclosure and Transparency Rules). This type of filing, which reports the total number of shares in issue and the resulting total voting rights denominator for shareholders, fits the definition of a regulatory announcement that doesn't fit a more specific financial report category. While it relates to share capital, it is a mandatory disclosure under transparency rules rather than a transaction (POS) or a general capital change (SHA). Given its nature as a routine regulatory update provided through the RNS system, it is best classified as a Regulatory Filing (RNS), which serves as a general category for such mandatory disclosures.
2024-07-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.